Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-04-01

Clinical Trial Update: Lubiprostone for Chronic Idiopathic Constipation Treatment [Phase 3]

View source ↗

Summary

Phase 3 trial for lubiprostone in chronic idiopathic constipation completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • LUBIPROSTONE (lubiprostone)

Snippet

Sponsor: Takeda | Conditions: Constipation | Phase 3 | Status: COMPLETED | Results posted: 2019-04-01